Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model
- 6 September 2014
- journal article
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (12) , 2607-2613
Abstract
Treatment of large-segmental bone defects still is a challenge in clinical routine. Application of gene-activated matrices (GAMs) based on fibrin, bone morphogenic protein (BMP) 2/7 plasmids and nonviral transfection reagents (cationic polymers) could be an innovative treatment strategy to overcome this problem. The aim of this study was to determine the therapeutic efficacy of fibrin GAMs with or without additional transfection reagents for BMP2 and 7 plasmid codelivery in a femur nonunion rat model. In this experimental study, a critical-sized femoral defect was created in 27 rats. At four weeks after the surgery, animals were separated into four groups and underwent a second operation. Fibrin clots containing BMP2/7 plasmids with and without cationic polymer were implanted into the femoral defect. Fibrin clots containing recombinant human (rh) BMP2 served as positive and clots without supplement as negative controls. At eight weeks, animals that received GAMs containing the cationic polymer and BMP2/7 plasmids showed decreased bone volume compared with animals treated with GAMs and BMP2/7 only. Application of BMP2/7 plasmids in fibrin GAMs without cationic polymer led to variable results. Animals that received rhBMP2 protein showed increased bone volume, and osseous unions were achieved in two of six animals. Cationic polymers decrease therapeutic efficiency of fibrin GAM-based BMP2/7 plasmid codelivery in bone regeneration. Nonviral gene transfer of BMP2/7 plasmids needs alternative promoters (e.g. by sonoporation, electroporation) to produce beneficial clinical effects.Keywords
This publication has 32 references indexed in Scilit:
- Constitutive and inducible co-expression systems for non-viral osteoinductive gene therapy2014
- Sonoporation Increases Therapeutic Efficacy of Inducible and Constitutive BMP2/7 In Vivo Gene DeliveryHuman Gene Therapy Methods, 2014
- Gene delivery to boneAdvanced Drug Delivery Reviews, 2012
- Use and efficacy of bone morphogenetic proteins in fracture healingInternational Orthopaedics, 2011
- Gene therapy for the regeneration of boneInjury, 2011
- Ultrasound-based nonviral gene delivery induces bone formation in vivoGene Therapy, 2007
- Fibrin‐embedded administration of VEGF plasmid enhances skin flap survivalWound Repair and Regeneration, 2007
- Combined Bone Morphogenetic Protein-2 and −7 Gene Transfer Enhances Osteoblastic Differentiation and Spine Fusion in a Rodent ModelJournal of Bone and Mineral Research, 2004
- Controlled release systems for DNA deliveryMolecular Therapy, 2004
- Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfectionJournal of Molecular Medicine, 2004